Private equity in 2022 closed on almost $90 billion in healthcare deals, according to an April 10 report from consulting firm Bain & Co.
The second highest year on record, 2023 saw huge PE interest in life sciences and biopharma sectors.
Here are three more key notes that ASC leaders need to know:
- The first half of 2022 saw a continuation of 2021's record-breaking healthcare private equity deal pace, but transactions slowed in the second half of the year.
- Value-based care and primary care continued to draw investment from private equity groups.
- More than 40 exits valued above $500 million were closed in 2022.